Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding CervoMed Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CRVO: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders4845−3
Shares2.28M2.17M−110.1K (−4.8%)
Value$20.9M$13.7M−$7.24M (−34.6%)

New holders (11)

Institutions that held CervoMed Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CRVO in Q2 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC76,080$478.2K0.00%
Jane Street Group, LLC65,939$414.4K0.00%
Goldman Sachs Group Inc21,199$133.2K0.00%
Thompson Davis & Co., Inc.13,950$87.7K0.06%
Susquehanna International Group, LLP13,075$82.2K0.00%
Marshall Wace, LLP12,017$75.6K0.00%
Squarepoint Ops LLC11,557$72.6K0.00%
HRT Financial LP10,434$65.0K0.00%
WFA of San Diego, LLC725$4.56K0.00%
Principal Securities, Inc.165$1.04K0.00%
Essential Partners LLC7$440.00%

Sold out (14)

Institutions that held CervoMed Inc. at the end of Q1 2025 and filed for Q2 2025 without it.